The National Cancer Moonshot initiative, USPTO launched Cancer Moonshot Expedited Examination Pilot Program replacing Cancer Immunotherapy Pilot Program, which expedited examination for eligible patent applications pertaining to methods of treating cancer using immunotherapy
To support the National Cancer Moonshot initiative, the USPTO launched the Cancer Moonshot Expedited Examination Pilot Program on February 1, 2023. The new program replaces the Cancer.
On February 1, 2023, the United States Patent & Trademark Office (USPTO) will begin accepting petitions to accelerate examination under the Cancer Moonshot Expedited Examination Pilot.
US Patent & Trademark Office PTO announced launch of Cancer Moonshot Expedited Examination Pilot Program. This program begins on February 1 2023 and replaces Cancer Immunotherapy Pilot Program. Cancer Moonshot Pilot run until January 31 2025 or 1000 grantable petitions.
On December 8, 2022, the US Patent & Trademark Office (PTO) announced the launch of the Cancer Moonshot Expedited Examination Pilot Program (Cancer Moonshot Pilot). This program begins.